The safety, efficacy and the predictive factors of efficacy of beclomethasone dipropionate (BDP) for acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatio
Phase 1
- Conditions
- Hematologic disorders gastrointestinal acute GVHD
- Registration Number
- JPRN-UMIN000007439
- Lead Sponsor
- Hematology,Graduate School of Medicine, Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients requiring systemic steroid treatment for grade 2 acute GVHD of skin and/or liver 2. Patients who cannot intake oral BDP 3. Uncontrollable infection in the gastrointestinal tract 4. Pregnant or possibility pregnant woman 5. Inappropriate to participate in this study as judged by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The complete response rate of gastrointestinal acute GVHD at day28 after starting treatment
- Secondary Outcome Measures
Name Time Method